Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Eur J Surg Oncol
    July 2026
  1. REESE T, Engstrand J, Bjork D, Ottestad AM, et al
    Propensity matched comparison between one-stage and two-stage hepatectomy after portal vein embolization for bilateral colorectal liver metastases.
    Eur J Surg Oncol. 2026;52:111884.
    >> Share

  2. PENEL N, Toulmonde M, Wallet J, LE Cesne A, et al
    Characteristics and outcome of intra-abdominal desmoid-type fibromatosis.
    Eur J Surg Oncol. 2026;52:111903.
    >> Share

  3. WILLIAMS A, Woods F, O'Neill C, Hutchings H, et al
    Using agile development methodology to develop a decision aid for complex rectal cancer.
    Eur J Surg Oncol. 2026;52:111813.
    >> Share

  4. DE ROO AC, Neuman HB
    Navigating the complexities of rectal cancer management: Shared decision-making and patient perspectives in critical choices.
    Eur J Surg Oncol. 2026;52:111738.
    >> Share

    June 2026
  5. RAFII S, Mukherji D, Chamseddine AN, Al-Shamsi HO, et al
    Immunotherapy and surgical decision-making in Lynch syndrome-associated colorectal cancer: Implications for personalized management and guideline revision.
    Eur J Surg Oncol. 2026;52:111948.
    >> Share

  6. WANG X, Jiang W, Sun Y, Tang Y, et al
    Distal margin length after neoadjuvant chemoradiotherapy has no prognostic impact in low rectal cancer once the margin is microscopically negative: A multicentre equivalence analysis.
    Eur J Surg Oncol. 2026;52:111465.
    >> Share

  7. SCARDINO A, Fiore M, Cavalleri T, Rausa E, et al
    The Inflammatory Biomarkers Prognostic Index (IBPI) obtained from standard preoperative blood tests predicts postoperative complications in patients undergoing pelvic exenteration for locally recurrent rectal cancer.
    Eur J Surg Oncol. 2026;52:111809.
    >> Share

  8. ZHOU J, Cui H, Lin Z, Qin S, et al
    The local efficacy of microwave ablation versus surgical resection for subcapsular colorectal liver metastases.
    Eur J Surg Oncol. 2026;52:111814.
    >> Share

  9. LAL N, Cheong Chung KJN, Hodges N, Jenkins JT, et al
    Prognostic significance of post-neoadjuvant MRI-detected extramural venous invasion and tumour deposits in rectal cancer: a systematic review and meta-analysis.
    Eur J Surg Oncol. 2026;52:111840.
    >> Share

  10. PAN Z, Zheng S, Zhuang Z, Wang Y, et al
    Development and validation of an ensemble machine learning model to predict survival in locally advanced rectal cancer: A multicenter, retrospective study.
    Eur J Surg Oncol. 2026;52:111815.
    >> Share

  11. HAN K, Zhou C, Zeng L, Lai X, et al
    MRI-driven multimodal deep learning approach for predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A multicenter study.
    Eur J Surg Oncol. 2026;52:111796.
    >> Share

    May 2026
  12. DANILUK-MARSY P, Castelein J, Polom K, Borra RJH, et al
    Interpretable and non-linear machine learning models for quantitative ICG perfusion assessment in colorectal cancer anastomosis: A feasibility study.
    Eur J Surg Oncol. 2026;52:111911.
    >> Share

  13. MOUAWAD C, Thouvenin A, Rozenbaum P, Pimpie C, et al
    First preclinical evaluation of a thermogel delivering mitomycin C: sustained local release with preserved surgical safety in a large animal model.
    Eur J Surg Oncol. 2026;52:111777.
    >> Share

  14. LAUWEREINS L, D'Hoore A, Coeckelberghs E, Wolthuis A, et al
    Development of S.Tool: An electronic diary for assessing bowel symptoms after rectal cancer surgery.
    Eur J Surg Oncol. 2026;52:111755.
    >> Share

  15. ZAMBRANO DA, Lintis A, Kefleyesus A, Taibi A, et al
    Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS real-life multicenter study.
    Eur J Surg Oncol. 2026;52:111731.
    >> Share

    April 2026
  16. SCARTON A, Kerkhoff TME, van Erning FN, Burger JWA, et al
    Conversion surgery after repeated intraperitoneal chemotherapy in unresectable peritoneal metastatic colorectal cancer: a narrative review of the literature.
    Eur J Surg Oncol. 2026;52:111803.
    >> Share

  17. PAU S, Eglinton T, Wang A, Fischer J, et al
    The role of artificial intelligence in pre-operative prediction of completeness of cytoreduction for peritoneal surface malignancies: a scoping review.
    Eur J Surg Oncol. 2026;52:111480.
    >> Share

  18. JACOBSEN S, Angenete E, Johnsson A, Lydrup ML, et al
    Long-term oncological outcomes after salvage surgery for anal squamous cell carcinoma - a national cohort study.
    Eur J Surg Oncol. 2026;52:111482.
    >> Share

  19. BUNJO Z, Seneviratne I, Murshed I, Bedrikovetski S, et al
    Statewide analysis of outcomes in patients with early-stage rectal cancer undergoing standard-of-care upfront resection.
    Eur J Surg Oncol. 2026;52:111484.
    >> Share

  20. FITZSIMMONS TR, Bunjo Z, Neo EL, Badiei A, et al
    Metastatic response and short-term survival outcomes in patients with stage IV rectal cancer treated with curative intent in the era of Total Neoadjuvant Therapy.
    Eur J Surg Oncol. 2026;52:111464.
    >> Share

    March 2026
  21. LV Y, Wang F, Shen Y, Yin S, et al
    Redefining the role of carbon nanoparticles in colorectal cancer surgery: From lymph node yield to diagnostic paradox.
    Eur J Surg Oncol. 2026;52:111782.
    >> Share

  22. SARTI K, El-Rawadi E, Gelli M, Beunon P, et al
    Targeting the liver: Insights from a tertiary center on post-operative hepatic arterial oxaliplatin for metastatic colorectal cancer.
    Eur J Surg Oncol. 2026;52:111511.
    >> Share

  23. NOIRET B, Kepenekian V, Leroy M, Provost M, et al
    Surgery for Colorectal Peritoneal Metastases in non-expert centers is strongly associated with tumor persistence or early recurrence: a bicentric study of 106 patients.
    Eur J Surg Oncol. 2026;52:111397.
    >> Share

  24. CASHIN PH, Morris D, Esquivel J, Larsen SG, et al
    The clinical benefit of a near complete cytoreduction in patients with colorectal peritoneal metastases: a propensity score matched study.
    Eur J Surg Oncol. 2026;52:111437.
    >> Share

  25. WANG Q, Xu L, Li B, Popuri K, et al
    Improved risk stratification in patients with colorectal liver metastases by incorporating volumetric body composition analysis.
    Eur J Surg Oncol. 2026;52:111402.
    >> Share

  26. GARFINKLE R, Balvardi S, Carmichael H, Shorr R, et al
    Outcomes reported in randomized controlled trials of rectal cancer treatment: A scoping review for the CORRECT initiative.
    Eur J Surg Oncol. 2026;52:111416.
    >> Share

  27. ZHAO Y, Chen Z, Wei Y, Zhou J, et al
    Clinical-radiological predictive model for preoperative risk stratification in rectal adenocarcinoma.
    Eur J Surg Oncol. 2026;52:111398.
    >> Share

  28. PISO T, Gerken M, Benz SR, Klinkhammer-Schalke M, et al
    Elective surgery in rectal cancer: long term results of a German network comparison of open, laparoscopic, and robotic surgery.
    Eur J Surg Oncol. 2026;52:111383.
    >> Share

    February 2026
  29. KITAGUCHI D, Forgione A, Innocenzi C, Yang Y, et al
    The role of complete mesocolic excision with central vascular ligation in colon cancer surgery: A systematic review and meta-analysis of prospective trials.
    Eur J Surg Oncol. 2026;52:111516.
    >> Share

  30. PLANELLAS P, Fernandes-Montes N, Alonso-Goncalves S, Golda T, et al
    External validation of a predictive system from the Swedish colorectal cancer registry to predict the risk of permanent stoma after rectal cancer surgery: A multicenter study in Spain.
    Eur J Surg Oncol. 2026;52:111512.
    >> Share

  31. MARTINEZ BRAVO JJ, Gogenur M, Gogenur I, Kiran RP, et al
    A prediction model for disease-free survival following R0/R1 rectal cancer resection: A retrospective longitudinal study based on the Norwegian and Danish colorectal cancer quality registries.
    Eur J Surg Oncol. 2026;52:111514.
    >> Share

  32. SCARDINO A, Wolthuis A, Taffurelli G, Dileo C, et al
    Readmission rates and predictive factors in older patients undergoing colorectal cancer surgery: A multicenter European retrospective study.
    Eur J Surg Oncol. 2026;52:111497.
    >> Share

  33. SLORDAHL KS, Balto A, Guren MG, Wibe A, et al
    Patient reported outcomes after treatment for colon cancer - A nationwide study.
    Eur J Surg Oncol. 2026;52:111481.
    >> Share

  34. HASIL L, Milks A, Panagakos A, Engel D, et al
    What is the impact of nutrition interventions on incidence of anastomotic leak after colorectal surgery? A systematic review of randomized trials.
    Eur J Surg Oncol. 2026;52:111321.
    >> Share

  35. UNE N, Kobayashi S, Kudo M, Sugimoto M, et al
    Response to chemotherapy as a key factor in time to surgical failure following conversion hepatectomy for initially unresectable colorectal liver metastases: A retrospective cohort study.
    Eur J Surg Oncol. 2026;52:111317.
    >> Share

  36. JISHU JA, Bruce D, Abu AlSel BT, Othman R, et al
    Minimally invasive approaches for early-stage rectal cancer: A comparative analysis from the TriNetX network.
    Eur J Surg Oncol. 2026;52:111318.
    >> Share

    January 2026
  37. GRANADOS-MATURANO A, Garcia-Nalda A, Pallisera-Lloveras A, Pujol-Caballe G, et al
    Colorectal cancer surgery in elderly and frail patients: Should we leave someone behind?
    Eur J Surg Oncol. 2026;52:111406.
    >> Share

  38. GLAZEMAKERS ST, Ketelaers SHJ, Cornelisse HB, de Wit F, et al
    Extended thromboprophylaxis in enhanced recovery after surgery for colorectal cancer: a multicentre retrospective cohort study.
    Eur J Surg Oncol. 2026;52:111378.
    >> Share

  39. ABERLE MR, Ligthart MAP, West MA, Rensen SS, et al
    Gain of visceral adipose tissue rather than low skeletal muscle mass is associated with overall survival in patients with colorectal liver metastases; results from the NewEPOC study.
    Eur J Surg Oncol. 2026;52:111179.
    >> Share

  40. BROWN KGM, Ng KS, Solomon MJ, Vu J, et al
    Preoperative predictors of priority outcomes of pelvic exenteration for locally recurrent rectal cancer: Results of the mixed-methods EviSurg study.
    Eur J Surg Oncol. 2026;52:111183.
    >> Share

  41. CICERONE O, Corallo S, De Silvestri A, Serra F, et al
    Anti-EGFR plus chemotherapy vs. chemotherapy alone in RAS wild-type colorectal liver metastases: A meta-analysis of survival outcomes in resectable and unresectable settings.
    Eur J Surg Oncol. 2026;52:111155.
    >> Share

    December 2025
  42. STICCA G, Soucisse M, Abou-Khalil M, Gervais MK, et al
    Safety of high-dose mitomycin C vs oxaliplatin HIPEC for peritoneal metastases.
    Eur J Surg Oncol. 2025;51:110534.
    >> Share

  43. CHATZIPANAGIOTOU OP, Kawashima J, Baldo A, Ruzzenente A, et al
    Time-varying hazards of recurrence patterns among patients with colorectal liver metastases undergoing liver resection and the role of the modified tumor burden score.
    Eur J Surg Oncol. 2025;51:110527.
    >> Share

  44. VAN DEN HEUVEL TBM, van Erning FN, Hemmer PHJ, Madsen EVE, et al
    Recurrence patterns following CRS-HIPEC in patients with colorectal peritoneal metastases: Insights from the Dutch CRS-HIPEC registry.
    Eur J Surg Oncol. 2025;51:110501.
    >> Share

  45. ALTINSOY E, Ozcan VC, Zeynalov H, Cebeci? E, et al
    An onco-vascular surgical approach: Internal iliac artery transposition for external iliac artery repair during cytoreductive surgery.
    Eur J Surg Oncol. 2025;51:110503.
    >> Share

  46. DE GRAAFF MR, Kok NFM, Grunhagen DJ, Nielen M, et al
    Influence of socioeconomic position on surgical outcomes after resection of colorectal liver metastases.
    Eur J Surg Oncol. 2025;51:110459.
    >> Share

  47. YE Q, Liu M, Xu M, Cui M, et al
    Correlation of supportive proton pump inhibitor use during surgery with outcomes in patients with stage I-III colorectal cancer: A propensity score matching study.
    Eur J Surg Oncol. 2025;51:110543.
    >> Share

  48. PAU S, Eglinton T, Wang A, Fischer J, et al
    Pre-operative predictors of completeness of cytoreduction for colorectal peritoneal metastases: a systematic review of radiological, clinicopathological and biomarker-based predictors.
    Eur J Surg Oncol. 2025;51:110537.
    >> Share

    November 2025
  49. EMILE SH, Horesh N, Wignakumar A, Boutros M, et al
    Advanced T stage and nodal disease are independently associated with worse cancer-specific survival in stage IV colorectal cancer: A SEER-based survival analysis.
    Eur J Surg Oncol. 2025;52:111315.
    >> Share

  50. BIRCH RJ, Taylor JC, Downing A, Burr NE, et al
    Understanding the relationship between surgical specialisation and outcomes following emergency surgery for colorectal cancer - a retrospective population-based study in the English NHS.
    Eur J Surg Oncol. 2025;52:111181.
    >> Share

  51. XIAO C, Zhang W, Qiu M, He D, et al
    A transformer-based pathomics model using endoscopic biopsy WSIs for predicting pathological complete response to preoperative immunotherapy in colorectal cancer.
    Eur J Surg Oncol. 2025;52:111182.
    >> Share

  52. LAU J, Ng A, Koh WL, Lee KY, et al
    The impact of colorectal cancer on quality of life of younger adults: A qualitative longitudinal approach.
    Eur J Surg Oncol. 2025;52:111169.
    >> Share

  53. YI T, Liang Y, Li X, Lin Z, et al
    Machine learning analysis for recurrence prediction of colorectal cancer liver metastases.
    Eur J Surg Oncol. 2025;52:111168.
    >> Share

  54. O'NEILL MA, Harrold EC, Gillham C, Ryan C, et al
    Immunotherapy for downstaging of locally advanced mismatch repair deficient colorectal cancer: A prospective institutional case series.
    Eur J Surg Oncol. 2025;52:111166.
    >> Share

  55. RIJSEMUS CJV, Kok NFM, Lahaye MJ
    Reply to Zhang, 'Comment on: Staging peritoneal metastases in colorectal cancer: The correlation between MRI, surgical and histopathological peritoneal cancer index'.
    Eur J Surg Oncol. 2025;51:109652.
    >> Share

  56. DE GRAAFF MR, Klaase JM, den Dulk M, Grunhagen DJ, et al
    Selection for local treatment and outcomes of surgical resection in patients with synchronous colorectal liver metastases: A nationwide population-based study.
    Eur J Surg Oncol. 2025;51:110411.
    >> Share

  57. DE LA MOTTE L, Tapper J, Arver S, Holm T, et al
    Long-term impact of preoperative radiotherapy for rectal cancer on testicular function.
    Eur J Surg Oncol. 2025;51:110458.
    >> Share

  58. MCKIGNEY N, van Rees JM, Nordkamp S, Waldenstedt S, et al
    Cross-cultural adaptation of the locally recurrent rectal cancer - Quality of life questionnaire.
    Eur J Surg Oncol. 2025;51:110363.
    >> Share

  59. ENBLAD M, Ghanipour L, Palmer G, Valdimarsson V, et al
    Prognosis and clinical characteristics of signet ring cell colorectal peritoneal metastases - a Swedish population-based study.
    Eur J Surg Oncol. 2025;51:110429.
    >> Share

  60. DENG Y, Li Y, Zhang R, Wang Z, et al
    Pre-treatment S-index as a promising prognostic indicator of treatment response and survival in patients with synchronous colorectal liver metastases: A retrospective multi-center study.
    Eur J Surg Oncol. 2025;51:110371.
    >> Share

  61. TEN BRINK R, Schram R, Kats-Ugurlu G, Kwee T, et al
    Feasibility of optical stereotactic navigation for rectosigmoid cancer with deep learning-supported 3D modelling.
    Eur J Surg Oncol. 2025;51:110397.
    >> Share

  62. MORGAN M, Ben C, Peter M, Fiachra C, et al
    Local excision versus total mesorectal excision following neoadjuvant chemoradiotherapy for rectal cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:110398.
    >> Share

  63. WILLIAMS A, O'Neill C, Hutchings H, Quyn A, et al
    Exploring decision making for treatment in LARC and LRRC: A qualitative study.
    Eur J Surg Oncol. 2025;51:110372.
    >> Share

    October 2025
  64. HANAOKA M, Kataoka K, Mizusawa J, Ouchi A, et al
    Risk of peritoneal recurrence following laparoscopic versus open surgery for stage II/III colorectal cancer: An integrated analysis of three Phase III randomized controlled trials (JCOG2310AS2).
    Eur J Surg Oncol. 2025;52:110545.
    >> Share

  65. BEN HMIDO S, Abder Rahim H, Ingwersen EW, Burchell G, et al
    Transparency in Externally Validated Models: A systematic review of machine learning vs. logistic regression for predicting colorectal anastomotic leakage.
    Eur J Surg Oncol. 2025;51:110367.
    >> Share

  66. GOBARDHAN PD, Veen EJ, Rijken AM, Ayez N, et al
    Video-assisted total transthoracic liver resection for colorectal liver metastasis, safety and feasibility.
    Eur J Surg Oncol. 2025;51:110389.
    >> Share

  67. KANG B, Qiao Y, Song J, Zhang Z, et al
    Interpretable machine learning model for predicting perioperative Clavien-Dindo III/IV complications of rectal cancer anterior resection after neoadjuvant therapy: a real-world study.
    Eur J Surg Oncol. 2025;51:110365.
    >> Share

  68. NAESSENS C, Evin C, Le-Malicot K, Lemanski C, et al
    Salvage abdominoperineal resection for anal squamous cell carcinoma after radiotherapy or chemoradiotherapy: analysis of the French prospective cohort FFCD-ANABASE.
    Eur J Surg Oncol. 2025;51:110346.
    >> Share

  69. GOULD LE, Pring ET, Wallace A, Hodges N, et al
    Clinical determinants of outcome following pelvic exenteration for locally advanced or locally recurrent rectal cancer.
    Eur J Surg Oncol. 2025;51:110347.
    >> Share

  70. WANG Z, Liu Q
    A retrospective analysis of 44 diminutive rectal neuroendocrine neoplasms that were not suitable for local treatment.
    Eur J Surg Oncol. 2025;51:110348.
    >> Share

  71. EMILE SH, Horesh N, Garoufalia Z, Wignakumar A, et al
    Association between the type of pre-existing adenoma and response of rectal cancer to neoadjuvant therapy.
    Eur J Surg Oncol. 2025;51:110319.
    >> Share

  72. WILLIAMS T, Hayler R, Garrett C, Barat S, et al
    Impact of diaphragmatic intervention in cytoreductive surgery with heated intraperitoneal chemotherapy for colorectal carcinoma.
    Eur J Surg Oncol. 2025;51:110306.
    >> Share

  73. GU YC, Yang M, Geng Y, Zhang B, et al
    Tumor-Boundary Response Index (TBRI)- A promising indicator for predicting outcomes in colorectal liver metastases receiving neoadjuvant therapy: Insights from a single-center retrospective study.
    Eur J Surg Oncol. 2025;51:110291.
    >> Share

    September 2025
  74. ZHOU Y, Zhao J, Tan Y, Zou F, et al
    CT-based radiomics deep learning signatures for noninvasive prediction of early recurrence after radical surgery in locally advanced colorectal cancer: A multicenter study.
    Eur J Surg Oncol. 2025;51:110482.
    >> Share

  75. HOANG VM, Turner B, Ho R, Tucker J, et al
    The impact of colorectal cancer diagnosis and treatment on quality of life is increased in young patients.
    Eur J Surg Oncol. 2025;51:110483.
    >> Share

  76. XIAO J, Gu C, Wu Q, Yang X, et al
    Feasibility of ambulatory colectomy in the tertiary hospital with surveillance in the community hospital: A propensity score-matched study.
    Eur J Surg Oncol. 2025;51:110077.
    >> Share

  77. CREEMERS DMJ, Mens DM, Nordkamp S, Piqeur F, et al
    Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohort.
    Eur J Surg Oncol. 2025;51:110261.
    >> Share

  78. NG JC, Sassun R, Sileo A, Violante T, et al
    Real-world clinical outcomes of total neoadjuvant therapy followed by total mesorectal excision for locally advanced rectal cancer at a high-volume institution.
    Eur J Surg Oncol. 2025;51:110181.
    >> Share

  79. HAQ MU, Pritchard DM, Hughes DM, Javed MA, et al
    Long-term outcomes of patients treated with contact X-ray brachytherapy and external beam (chemo)radiotherapy following local excision of rectal adenocarcinoma.
    Eur J Surg Oncol. 2025;51:110216.
    >> Share

  80. NOIRET B, Koo CH, Bacci M, Lamichhane NB, et al
    Clinical contexts for Shared Decision-Making in rectal cancer: Organ preservation, sphincter-sparing surgery and tailored stoma policy.
    Eur J Surg Oncol. 2025;51:110196.
    >> Share

  81. MENS DM, Coebergh van den Braak RRJ, Hilling DE, Meyer V, et al
    Nationwide analysis on the role of neoadjuvant radiotherapy and watch and wait in rectal cancer.
    Eur J Surg Oncol. 2025;51:110179.
    >> Share

  82. MENS DM, van Rees JM, Husson O, Crolla RMPH, et al
    Impact of minimal invasive surgery techniques on long-term health-related quality of life in rectal cancer: a Dutch cohort study.
    Eur J Surg Oncol. 2025;51:110180.
    >> Share

  83. KEFLEYESUS A, Bakrin N, Kepenekian V, Gerbaud-Coulas C, et al
    Enhanced recovery for cytoreductive surgery and hyperthermic intraperitoneal Chemotherapy: An international survey to assess acceptance and feasibility.
    Eur J Surg Oncol. 2025;51:110150.
    >> Share

    August 2025
  84. LUNDSTROM S, Agger E, Lydrup ML, Jorgren F, et al
    Rethinking TNM: Tumor deposit-based prognostic models may improve N-staging in colorectal cancer.
    Eur J Surg Oncol. 2025;51:110420.
    >> Share

  85. SABAJO CR, Michels CTJ, van der Hout A, van den Heuvel B, et al
    The financial impact of implementation of a prehabilitation program for colorectal cancer patients in the Netherlands: A budget impact analysis.
    Eur J Surg Oncol. 2025;51:110375.
    >> Share

  86. CATARCI M, Guadagni S, Scatizzi M, De Luca R, et al
    Enhanced recovery and survival after elective surgery for colorectal cancer - propensity score weighting analysis of 2,865 prospective patients.
    Eur J Surg Oncol. 2025;51:110379.
    >> Share

  87. GOOIJER SA, Gazendam ASM, Torensma B, Tuynman JB, et al
    Metastasectomy versus stereotactic body radiotherapy for patients with oligometastatic colorectal lung metastases: a systematic review.
    Eur J Surg Oncol. 2025;51:110056.
    >> Share

  88. KAZI M, Ajith A, Bhatt A
    The Mitomycin versus Oxaliplatin debate on HIPEC in colorectal cancers - An updated systematic review and Meta-analysis.
    Eur J Surg Oncol. 2025;51:110080.
    >> Share

  89. HORESH N, Emile SH, Garoufalia Z, Gefen R, et al
    Network meta-analysis of RTCs for efficacy of neoadjuvant treatment in rectal cancer.
    Eur J Surg Oncol. 2025;51:110019.
    >> Share

  90. TSAI ML, Hung JS, Huang J, Lin BR, et al
    Factors associated with leakage after reversal of protective stoma in patients with locally advanced rectal cancer following curative resection and anastomosis.
    Eur J Surg Oncol. 2025;51:108698.
    >> Share

  91. SU YM, Jin KM, Wang HW, Wang YY, et al
    Survival prediction of colorectal liver metastases underwent surgical resection after neoadjuvant chemotherapy: Tumor response combined with the genetic and morphological evaluation score.
    Eur J Surg Oncol. 2025;51:108777.
    >> Share

    July 2025
  92. MA Y
    Comment on "A deep-learning model to predict the completeness of cytoreductive surgery in colorectal cancer with peritoneal metastasis".
    Eur J Surg Oncol. 2025;51:110315.
    >> Share

  93. ZOU M, Yang Z, Feng J, Yang Z, et al
    Comment on: "Muscle-specific strength predicts postoperative complications and survival in patients undergoing curative colectomy for colorectal cancer".
    Eur J Surg Oncol. 2025;51:110321.
    >> Share

  94. ABUDUAINI N, Wang X, Fingerhut A, Zheng M, et al
    Short-term outcomes of transanal endoscopic intersphincteric resection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A single-center retrospective cohort study.
    Eur J Surg Oncol. 2025;51:109984.
    >> Share

  95. POWELL SG, Wyatt JNR, Rao C, Dhadda A, et al
    Contact X-ray brachytherapy in rectal cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:109976.
    >> Share

  96. WETTERHOLM E, Ronnow CF, Thorlacius H
    Risk of recurrence following transanal endoscopic microsurgery without neoadjuvant or adjuvant treatment in T2 rectal cancer.
    Eur J Surg Oncol. 2025;51:109974.
    >> Share

  97. JEHAES C, Panis Y, Fernandez L, Lelong B, et al
    Risk of distant metastasis after local excision for near-complete response versus salvage surgery for local regrowth in rectal cancer: Results from an international registry.
    Eur J Surg Oncol. 2025;51:109761.
    >> Share

  98. BANKEN E, Creemers DMJ, Kerckhove FECV, Ketelaers SHJ, et al
    Palliative management of patients with locally recurrent rectal cancer: Clinical presentation, treatment strategies, and overall survival.
    Eur J Surg Oncol. 2025;51:109758.
    >> Share

  99. BHIMANI N, Dieng M, Kelly PJ, Hugh TJ, et al
    Colorectal liver metastasis resection results in excellent long-term quality of life and low symptom burden.
    Eur J Surg Oncol. 2025;51:109751.
    >> Share

  100. FOPPA C, Maroli A, Carvello M, La Raja C, et al
    Long-term functional outcomes after Transanal Transection and Single-Stapled (TTSS) anastomosis for rectal cancer measured by electronic Patients Reported Outcome Measures (ePROMs).
    Eur J Surg Oncol. 2025;51:109759.
    >> Share

  101. BOLDRINI L, Charles-Davies D, Romano A, Mancino M, et al
    Response prediction for neoadjuvant treatment in locally advanced rectal cancer patients-improvement in decision-making: A systematic review.
    Eur J Surg Oncol. 2025;51:109463.
    >> Share

    June 2025
  102. LIU W, He F, Chen D, Zhang X, et al
    Impact of previous abdominal surgery on minimally invasive radical resection of colorectal cancer: A meta-analysis.
    Eur J Surg Oncol. 2025;51:110259.
    >> Share

  103. GOEDEGEBUURE EP, Arico FM, Lahaye MJ, Maas M, et al
    Defining the tumor location in rectal cancer - Practice variations and impact on treatment decision making.
    Eur J Surg Oncol. 2025;51:109700.
    >> Share

  104. SU J, Liu Z, Li H, Kang L, et al
    Artificial intelligence-based model to predict recurrence after local excision in T1 rectal cancer.
    Eur J Surg Oncol. 2025;51:109717.
    >> Share

  105. BOND MJG, Verhoef C, Kazemier G, Kok NFM, et al
    Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment.
    Eur J Surg Oncol. 2025;51:109681.
    >> Share

  106. AHMADINEJAD M, Parvizi A, Sheikhi S, Eghbal F, et al
    Optimal timing of surgery after neoadjuvant chemoradiotherapy in rectal cancer: A retrospective analysis.
    Eur J Surg Oncol. 2025;51:109702.
    >> Share

  107. MOOLENAAR LR, van Geffen EGM, Hazen SJA, Sluckin TC, et al
    Salvageable locoregional recurrence and stoma rate after local excision of pT1-2 rectal cancer - A nationwide cross-sectional cohort study.
    Eur J Surg Oncol. 2025;51:109623.
    >> Share

  108. MONTALTI R, Pepe F, Cassese G, Russo G, et al
    Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study.
    Eur J Surg Oncol. 2025;51:109706.
    >> Share

    May 2025
  109. WOERNER J, Nam Y, Jung SH, Shivakumar M, et al
    Leveraging automated machine learning to predict colon cancer prognosis from clinical features and risk groups: a retrospective cohort study.
    Eur J Surg Oncol. 2025;51:110194.
    >> Share

  110. ZHANG Y, Li J, Guan X, Wang S, et al
    Impact of lymph node metastasis on prognosis in colorectal cancer patients with liver metastasis and staging systems Refinement: An international multicenter retrospective cohort study.
    Eur J Surg Oncol. 2025;51:110124.
    >> Share

  111. AWAIS AM, Awais AR
    LTE: Enhancing colorectal cancer patient selection for cytoreductive surgery: The role of artificial intelligence and integration of pathological peritoneal cancer index in improving clinical outcomes.
    Eur J Surg Oncol. 2025;51:110122.
    >> Share

  112. LAKHA AS, Sud V, Alemour Y, Perera NJ, et al
    Simultaneous versus delayed resection of synchronous colorectal liver metastases: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:109732.
    >> Share

  113. VAN DEN BERG K, Banken E, van Rees JM, Coolen LM, et al
    Neoadjuvant chemotherapy and chemoradiotherapy versus chemoradiotherapy alone in high-risk locally advanced rectal cancer: A retrospective comparison of two Dutch tertiary referral centres.
    Eur J Surg Oncol. 2025;51:109699.
    >> Share

  114. MAEKAWA A, Omiya K, Oba A, Inoue Y, et al
    Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases.
    Eur J Surg Oncol. 2025;51:109635.
    >> Share

  115. YANG W, Li C, Luo J, Feng Y, et al
    Transcatheter rectal arterial chemoembolization with oxaliplatin and concurrent chemoradiotherapy in patients with locally advanced rectal cancer: A retrospective comparative study.
    Eur J Surg Oncol. 2025;51:109582.
    >> Share

    April 2025
  116. ASSI H, Valdimarsson V, Angenete E, Buchwald P, et al
    Survival after urological resections in colorectal cancer - a Swedish nationwide study.
    Eur J Surg Oncol. 2025;51:110078.
    >> Share

  117. JESSEN SB, Vogelsang RP, Dolin TG, Jorgensen J, et al
    Surgery-related change in cancer cell adhesion associates with recurrence in patients undergoing colorectal cancer surgery.
    Eur J Surg Oncol. 2025;51:110055.
    >> Share

  118. ZHAI WB, Li ZZ, He CH, Xi WT, et al
    Muscle-specific strength predicts postoperative complications and survival in patients undergoing curative colectomy for colorectal cancer.
    Eur J Surg Oncol. 2025;51:110020.
    >> Share

    March 2025
  119. VAN GANSEWINKEL EHE, van den Heuvel TBM, van Erning FN, De Hingh IHJT, et al
    Combined peritoneal and liver metastases in colorectal cancer: A Dutch nationwide population-based analysis of incidence, treatment and survival.
    Eur J Surg Oncol. 2025;51:109999.
    >> Share

  120. PAWAR A, Kepenekian V, Omar A, Bel N, et al
    Influence of lung metastases on outcomes of curative management of peritoneal metastases from colorectal cancer.
    Eur J Surg Oncol. 2025;51:109650.
    >> Share

  121. LIN Q, Chen C, Li K, Cao W, et al
    A deep-learning model to predict the completeness of cytoreductive surgery in colorectal cancer with peritoneal metastasis?.
    Eur J Surg Oncol. 2025;51:109760.
    >> Share

  122. ZHANG X, Chen J, He F, Du W, et al
    Comparing efficacy and safety of transanal vs. laparoscopic total mesorectal excision for middle and low rectal cancer: Updated meta-analysis.
    Eur J Surg Oncol. 2025;51:109559.
    >> Share

  123. TWEED TTT, Tummers S, Boerma EG, Bouvy ND, et al
    Minimal invasive surgery protects against severe postoperative complications regardless of body composition in patients undergoing colorectal surgery.
    Eur J Surg Oncol. 2025;51:109561.
    >> Share

  124. QIU W, Hu G, Mei S, Li Y, et al
    Indocyanine green highlights the lymphatic drainage pathways, enhancing the effectiveness of radical surgery for mid-low rectal cancer: A non-randomized controlled prospective study.
    Eur J Surg Oncol. 2025;51:109520.
    >> Share

  125. MATEUSIAK L, Hakuno S, de Jonge-Muller ESM, Floru S, et al
    Fluorescent Nanobodies for enhanced guidance in digestive tumors and liver metastasis surgery.
    Eur J Surg Oncol. 2025;51:109537.
    >> Share

  126. AMMIRABILE A, Cavinato L, Ferro CAP, Fiz F, et al
    CT-radiomics and pathological tumor response to systemic therapy: A predictive analysis for colorectal liver metastases. Development and internal validation of a clinical-radiomic model.
    Eur J Surg Oncol. 2025;51:109557.
    >> Share

    February 2025
  127. CARRION-ALVAREZ L, Primavesi F, Soreide K, Sochorova D, et al
    Liver metastases from colorectal cancer: A joint ESSO-EAHPBA-UEMS core curriculum collaboration.
    Eur J Surg Oncol. 2025;51:109728.
    >> Share

  128. TIWARI A, Lee SL, MacCabe T, Woyton M, et al
    Intraoperative electron radiotherapy (IOERT) in colorectal cancer: Updated systematic review of techniques, oncological outcomes and complications.
    Eur J Surg Oncol. 2025;51:109724.
    >> Share

  129. GHABRA S, Chang D, Sugarbaker PH
    Preoperative tumor marker elevations in colorectal cancer patients with peritoneal metastases should be used to help select patients for cytoreductive surgery.
    Eur J Surg Oncol. 2025;51:109720.
    >> Share

  130. ALTAF A, Kawashima J, Khalil M, Stecko H, et al
    Identification of a gene signature and prediction of overall survival of patients with stage IV colorectal cancer using a novel machine learning approach.
    Eur J Surg Oncol. 2025;51:109718.
    >> Share

  131. TANG J, Liao L, Xiao B, Sui Q, et al
    Efficacy and safety of subtotal pelvic peritonectomy for colorectal cancer patients with peritoneal metastasis confined to the pelvic cavity.
    Eur J Surg Oncol. 2025;51:109703.
    >> Share

  132. GIRARDI L, Mallick R, Wang TF, Carrier M, et al
    Efficacy and safety of extended duration postoperative thromboprophylaxis with low molecular weight heparin among subgroups of patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.
    Eur J Surg Oncol. 2025;51:109701.
    >> Share

  133. GROEN LC, Timmers TG, Daams FD, Doodeman HJ, et al
    Fit4Surgery app: Home-based prehabilitation app for older patients undergoing elective colorectal cancer surgery.
    Eur J Surg Oncol. 2025;51:109691.
    >> Share

  134. WONG CS, Zaman S, Siddiraju K, Sellvaraj A, et al
    Reply to: Comment on "Effects of enteral immunonutrition in laparoscopic versus open resections in colorectal cancer surgery: A meta-analysis of randomised controlled trials".
    Eur J Surg Oncol. 2025 Feb 6:109655. doi: 10.1016/j.ejso.2025.109655.
    >> Share

  135. CHEN J, Liu X
    Comment on "Effects of enteral immunonutrition in laparoscopic versus open resections in colorectal cancer surgery: A meta-analysis of randomized controlled trials".
    Eur J Surg Oncol. 2025;51:109656.
    >> Share

  136. YANAGISAWA T, Tatematsu N, Asano S, Horiuchi M, et al
    Perioperative decline in isometric knee extension force is a predictor of unplanned readmission within 1 year in patients with colorectal cancer.
    Eur J Surg Oncol. 2025;51:109673.
    >> Share

  137. WANG X
    Revisiting colonic obstruction criteria and optimal timing for SEMS placement in colon cancer.
    Eur J Surg Oncol. 2025;51:109631.
    >> Share

  138. BAE SU, Lee JL, Yang CS, Park EJ, et al
    Survival benefit of adjuvant chemotherapy in high-risk patients with colon cancer regardless of microsatellite instability.
    Eur J Surg Oncol. 2025;51:109674.
    >> Share

  139. VEEN T, Kanani A, Zaharia C, Lea D, et al
    Treatment-sequencing before and after index hepatectomy with either synchronous or metachronous colorectal liver metastasis: Comparison of recurrence risk, repeat hepatectomy and overall survival in a population-derived cohort.
    Eur J Surg Oncol. 2025;51:109540.
    >> Share

  140. NG WH, Machado C, Rooney A, Jones R, et al
    Ablative techniques in colorectal liver metastases: A systematic review, descriptive summary of practice, and recommendations for optimal data reporting.
    Eur J Surg Oncol. 2025;51:109487.
    >> Share

  141. BRIERE R, Simard AJ, Rouleau-Fournier F, Letarte F, et al
    Perioperative management and survival outcomes following cytoreductive surgery in patients with peritoneal metastases from rectal cancer: A scoping review.
    Eur J Surg Oncol. 2025;51:109498.
    >> Share

    January 2025
  142. LIU X, Zhang CJ
    Reply to: Comment on "Staging peritoneal metastases in colorectal cancer: The correlation between MRI, surgical and histopathological peritoneal cancer index".
    Eur J Surg Oncol. 2025 Jan 30:109653. doi: 10.1016/j.ejso.2025.109653.
    >> Share

  143. MEHTA R, Sah R, Kumar S
    Comment on "Effects of enteral immunonutrition in laparoscopic versus open resections in colorectal cancer surgery: A meta-analysis of randomised controlled trials".
    Eur J Surg Oncol. 2025 Jan 28:109637. doi: 10.1016/j.ejso.2025.109637.
    >> Share

  144. WONG CS, Zaman S, Siddiraju K, Sellvaraj A, et al
    Reply to comment on "Effects of enteral immunonutrition in laparoscopic versus open resections in colorectal cancer surgery: A meta-analysis of randomised controlled trials".
    Eur J Surg Oncol. 2025 Jan 28:109636. doi: 10.1016/j.ejso.2025.109636.
    >> Share

  145. RIJSEMUS CJV, Kok NFM, Aalbers AGJ, Grotenhuis BA, et al
    Can surgeons predict the extent of abdominal surgery based on MRI findings in CRS-HIPEC candidates with colorectal cancer?
    Eur J Surg Oncol. 2025;51:109583.
    >> Share

  146. JERI-MCFARLANE S, Garcia-Granero A, Martinez-Ortega MA, Amengual-Antich I, et al
    Tailored-surgery for locally advanced colon cancer based on 3D mathematical reconstruction surgical planner: Observational comparative non-randomized study.
    Eur J Surg Oncol. 2025;51:109584.
    >> Share

  147. RAUNKILDE L, Andersen RF, Thomsen CB, Hansen TF, et al
    A prospective study of methylated ctDNA in patients undergoing treatment for liver metastases from colorectal cancer.
    Eur J Surg Oncol. 2025;51:109586.
    >> Share

  148. KEARNS EC, Moynihan A, Khan MF, Lawler L, et al
    Comparison and impact of preoperative 3D virtual vascular modelling with intraoperative indocyanine green perfusion angiography for personalized proximal colon cancer surgery.
    Eur J Surg Oncol. 2025;51:109581.
    >> Share

  149. DE'ANGELIS N, Schena CA, Azzolina D, Carra MC, et al
    Histopathological outcomes of transanal, robotic, open, and laparoscopic surgery for rectal cancer resection. A Bayesian network meta-analysis of randomized controlled trials.
    Eur J Surg Oncol. 2025;51:109481.
    >> Share

  150. SOURROUILLE I, Pastier C, Gelli M, Benhaim L, et al
    Results of complete cytoreductive strategy in patients with peritoneal metastases of colorectal origin with or without extraperitoneal metastases: A bicentric analysis.
    Eur J Surg Oncol. 2025;51:108788.
    >> Share

  151. GALANOS LJK, Rijken A, Elferink MAG, Boerma D, et al
    Differences in patient- and tumor characteristics, treatment and survival between patients with screen-detected versus clinically detected colorectal peritoneal metastases.
    Eur J Surg Oncol. 2025;51:108789.
    >> Share

    December 2024
  152. VAN DEN BERG K, van Hellemond IEG, Willems JMWE, Burger JWA, et al
    Neoadjuvant chemotherapy in locally advanced colon cancer: A systematic review with proportional meta-analysis.
    Eur J Surg Oncol. 2024;51:109560.
    >> Share

  153. LOCKHORST EW, Boeding JRE, Wullaert L, Coebergh van den Braak RRJ, et al
    Long-term outcomes after postponing surgery to optimise patients with acute right-sided obstructing colon cancer.
    Eur J Surg Oncol. 2024;51:109521.
    >> Share

  154. BOLMSTRAND B, Nilsson PJ, Eloranta S, Martling A, et al
    Survival after surgery beyond total mesorectal excision for primary locally advanced rectal cancer, a population-based study.
    Eur J Surg Oncol. 2024;50:108673.
    >> Share

  155. MCKIGNEY N, Downing A, Velikova G, Brown JM, et al
    Registry-based study comparing health-related quality of life between patients with primary rectal cancer and locally recurrent rectal cancer.
    Eur J Surg Oncol. 2024;50:108736.
    >> Share

  156. WANG Y, Pan Z, Li S, Cai H, et al
    Prediction and validation of pathologic complete response for locally advanced rectal cancer under neoadjuvant chemoradiotherapy based on a novel predictor using interpretable machine learning.
    Eur J Surg Oncol. 2024;50:108738.
    >> Share

  157. HUANG F, Xiao T, Shen G, Zhou S, et al
    Lateral lymph node metastasis without mesenteric lymph node involvement in middle-low rectal cancer: Results of a multicentre lateral node collaborative group study in China.
    Eur J Surg Oncol. 2024;50:108737.
    >> Share

  158. SU Y, Li Y, Yang W, Luo X, et al
    Optimized machine learning model for predicting unplanned reoperation after rectal cancer anterior resection.
    Eur J Surg Oncol. 2024;50:108703.
    >> Share

  159. GONELLA F, Massucco P, Perotti S, Gianolio S, et al
    Prehab, ERAS, Rehab: A patient care continuum around colo-rectal surgery: Prehabilitation combined with ERAS and rehabilitation to reduce morbidity and hospital stay.
    Eur J Surg Oncol. 2024;50:108688.
    >> Share

  160. RIVERA D, Prades J, Borras JM, Aliste L, et al
    Multidisciplinary team meetings and their impact on survival in rectal cancer. Population-based analysis in Catalonia (Spain).
    Eur J Surg Oncol. 2024;50:108675.
    >> Share

  161. GARFINKLE R, Bews KA, Perry WRG, Behm KT, et al
    Postoperative bowel dysfunction in patients with rectal cancer - Does a minimally invasive surgical approach improve outcomes?
    Eur J Surg Oncol. 2024;50:108661.
    >> Share

  162. VAN ERNING FN, van den Heuvel TBM, Sijtsma FPC, Boerma D, et al
    An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry.
    Eur J Surg Oncol. 2024;50:108568.
    >> Share

  163. KOLBINGER FR, Bodenstedt S, Carstens M, Leger S, et al
    Artificial Intelligence for context-aware surgical guidance in complex robot-assisted oncological procedures: An exploratory feasibility study.
    Eur J Surg Oncol. 2024;50:106996.
    >> Share

    November 2024
  164. WONG CS, Zaman S, Siddiraju K, Sellvaraj A, et al
    Effects of enteral immunonutrition in laparoscopic versus open resections in colorectal cancer surgery: A meta-analysis of randomised controlled trials.
    Eur J Surg Oncol. 2024;51:109488.
    >> Share

  165. PENNINGS AJ, Kimman ML, Renehan AG, Perez RO, et al
    A patient reported outcome measure for rectal cancer patients eligible for organ preservation: Development and validation of a Watch-and-Wait module for the Assessment of Burden of disease in ColoRectal Cancer (ABCRC) tool.
    Eur J Surg Oncol. 2024;51:109501.
    >> Share

  166. DUAN M, Liu Z, Qiao Y, Huang P, et al
    Clinical significance of positive resection margin for patients with rectal neuroendocrine tumors within 20 mm following initial endoscopic resection: A multi-center study.
    Eur J Surg Oncol. 2024;50:108651.
    >> Share

  167. MEILLAT H, Weets V, Saadoun JE, Tyran M, et al
    Improving the local excision strategy for rectal cancer after chemoradiotherapy: Surgical and oncological results.
    Eur J Surg Oncol. 2024;50:108639.
    >> Share

  168. RUSSOLILLO N, Zingaretti CC, Langella S, Fontana AP, et al
    GAME-SCORE predicts pathological and radiological response to chemotherapy in patients with colorectal liver metastases.
    Eur J Surg Oncol. 2024;50:108529.
    >> Share

  169. KIM S, Huh JW, Lee WY, Yun SH, et al
    Risk factors and treatment strategies for local recurrence of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by total mesorectal excision.
    Eur J Surg Oncol. 2024;50:108641.
    >> Share

  170. EMILE SH, Garoufalia Z, Dourado J, Salama E, et al
    Predictors and outcomes of delays between diagnosis and definitive surgery for rectal cancer.
    Eur J Surg Oncol. 2024;50:108618.
    >> Share

  171. MAKKER PGS, Koh CE, Solomon M, El-Hayek J, et al
    The influence of postoperative morbidity on long-term quality of life outcomes following pelvic exenteration.
    Eur J Surg Oncol. 2024;50:108640.
    >> Share

    October 2024
  172. KANG JH, Kim EM, Kim MJ, Oh BY, et al
    Comparative analysis of the oncologic outcomes and risk factors for open conversion in laparoscopic surgery for non-metastatic colorectal cancer: A retrospective multicenter study.
    Eur J Surg Oncol. 2024;51:109357.
    >> Share

  173. NALLY DM, Kearns EC, Dalli J, Moynagh N, et al
    Patient public perspectives on digital colorectal cancer surgery (DALLAS).
    Eur J Surg Oncol. 2024 Oct 20:108705. doi: 10.1016/j.ejso.2024.108705.
    >> Share

  174. KAVASI SB, Iov DE, Rancz A, Zolcsak A, et al
    End-to-end anastomosis provides similar quality-of-life, compared with other reconstructive techniques six months following total mesorectal excision: Systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108599.
    >> Share

  175. HUGEN N, Voorham QJM, Beets GL, Loughrey MB, et al
    The mode of circumferential margin involvement in rectal cancer determines its impact on outcomes: A population-based study.
    Eur J Surg Oncol. 2024;50:108598.
    >> Share

  176. JAQUET R, Challine A, Tzedakis S, de Ponthaud C, et al
    Impact of the thresholds of surgical volume on mortality in oncological digestive surgery: A French National Cohort.
    Eur J Surg Oncol. 2024;50:108581.
    >> Share

  177. ISHIZUKA M, Shibuya N, Hachiya H, Nishi Y, et al
    Robotic surgery is associated with a decreased risk of circumferential resection margin positivity compared with conventional laparoscopic surgery in patients with rectal cancer undergoing mesorectal excision: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108538.
    >> Share

  178. YANG X, Bi X
    Reply to "A nomogram for predicting colorectal cancer liver metastasis using circulating tumor cells from the first drainage vein".
    Eur J Surg Oncol. 2024;50:108728.
    >> Share

    September 2024
  179. CHONG-JIE Z
    Comment on "A nomogram for predicting colorectal cancer liver metastasis using circulating tumor cells from the first drainage vein".
    Eur J Surg Oncol. 2024;50:108729.
    >> Share

  180. FRANSSEN R, Voorn M, Jetten E, Bongers BC, et al
    Real-life effectiveness of prehabilitation to improve postoperative outcomes in patients with colorectal cancer approaching surgery: A systematic review and meta-analyses of observational studies versus randomized controlled trials.
    Eur J Surg Oncol. 2024;50:108708.
    >> Share

  181. LIAO CK, Hsu YJ, Chern YJ, Yu YL, et al
    Differences in characteristics and outcomes between early-onset colorectal cancer and late-onset colorectal cancers.
    Eur J Surg Oncol. 2024;50:108687.
    >> Share

  182. XIA L, Xu X, Zhang C, Cao G, et al
    Low pneumoperitoneum pressure on venous thromboembolism in laparoscopic colorectal cancer surgery: A randomized controlled study.
    Eur J Surg Oncol. 2024;50:108672.
    >> Share

  183. HANSEN SB, Fonnes S, Oggesen BT, Rosenberg J, et al
    High prevalence of erectile dysfunction within the first year after surgery for rectal cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108662.
    >> Share

  184. KAWASHIMA J, Chatzipanagiotou OP, Tsilimigras DI, Khan MMM, et al
    Preoperative and postoperative predictive models of early recurrence for colorectal liver metastases following chemotherapy and curative-intent one-stage hepatectomy.
    Eur J Surg Oncol. 2024;50:108532.
    >> Share

  185. SUN Y, Jiang W, Tang Z, Wang X, et al
    Textbook outcome in low rectal cancer after neoadjuvant chemoradiotherapy: Post hoc analysis of the LASRE randomized clinical trial.
    Eur J Surg Oncol. 2024;50:108519.
    >> Share

  186. FRUHLING P, Stillstrom D, Holmquist F, Nilsson A, et al
    Change in tissue resistance after irreversible electroporation in liver tumors as an indicator of treatment success - A multi-center analysis with long term follow-up.
    Eur J Surg Oncol. 2024;50:108508.
    >> Share

  187. RAUWERDINK P, van de Vlasakker VCJ, Wassenaar ECE, Rovers KP, et al
    First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II).
    Eur J Surg Oncol. 2024;50:108487.
    >> Share

  188. DUMONT F, Kepenekian V, Passot C, Ezanno-Manasterski AC, et al
    PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial.
    Eur J Surg Oncol. 2024;50:108468.
    >> Share

    August 2024
  189. TRINIDAD-GUTIERREZ I, Vazquez-Borrego MC, Aguilera-Fernandez E, Velez-Castano JE, et al
    Efficacy of systemic Chemotherapy on high-risk stage II and III Mucnious colon cancer. CHEMUCCA study part I.
    Eur J Surg Oncol. 2024;50:108642.
    >> Share

  190. RIJSEMUS CJV, Kok NFM, Aalbers AGJ, Fijneman RJA, et al
    Staging peritoneal metastases in colorectal cancer: The correlation between MRI, surgical and histopathological peritoneal cancer index.
    Eur J Surg Oncol. 2024;50:108611.
    >> Share

  191. KEARNS EC, Moynihan A, Dalli J, Khan MF, et al
    Clinical validation of 3D virtual modelling for laparoscopic complete mesocolic excision with central vascular ligation for proximal colon cancer.
    Eur J Surg Oncol. 2024;50:108597.
    >> Share

  192. YANG X, Zhang Z, Bi X
    A nomogram for predicting colorectal cancer liver metastasis using circulating tumor cells from the first drainage vein.
    Eur J Surg Oncol. 2024;50:108579.
    >> Share

    July 2024
  193. AHMED M, Nabi R, Nadeem M
    Enhancing patient-centered care and addressing psychosocial needs in colorectal cancer: The role of the ABCRC tool.
    Eur J Surg Oncol. 2024 Jul 26:108551. doi: 10.1016/j.ejso.2024.108551.
    >> Share

  194. THOMASSEN BJM, Kimman ML, Somers AMJ, Ponds RWHM, et al
    Reply to: 'Enhancing patient-centered care and addressing psychosocial needs in colorectal cancer: The role of the ABCRC tool'.
    Eur J Surg Oncol. 2024 Jul 20:108552. doi: 10.1016/j.ejso.2024.108552.
    >> Share

  195. BAIK H, Kim J, Seo SH, Kim KH, et al
    Shorter interval to surgery after self-expanding metallic stent may result in better oncologic outcomes in colon cancer obstruction.
    Eur J Surg Oncol. 2024;50:108539.
    >> Share

  196. WANG X
    Critical appraisal of multidisciplinary treatment outcomes in young-onset colorectal cancer with synchronous liver metastases: A retrospective analysis and methodological considerations.
    Eur J Surg Oncol. 2024 Jul 3:108521. doi: 10.1016/j.ejso.2024.108521.
    >> Share

  197. SU Y, Li Y, Zhang H, Yang W, et al
    Machine learning model for prediction of permanent stoma after anterior resection of rectal cancer: A multicenter study.
    Eur J Surg Oncol. 2024;50:108386.
    >> Share

    June 2024
  198. MAKI H, Vauthey JN, You YN
    Reply to: Critical Appraisal of multidisciplinary treatment outcomes in young-onset colorectal cancer with synchronous liver metastases: A retrospective analysis and methodological Considerations.
    Eur J Surg Oncol. 2024 Jun 29:108520. doi: 10.1016/j.ejso.2024.108520.
    >> Share

  199. AWAIS AR, Manzoor I, Mansoor M
    Harnessing machine learning to predict colorectal cancer metastasis: A promising artificial intelligence frontier.
    Eur J Surg Oncol. 2024 Jun 26:108493. doi: 10.1016/j.ejso.2024.108493.
    >> Share

  200. JAMES AL, Lattimore CM, Cramer CL, Mubang ET, et al
    The impact of geriatric-specific variables on long-term outcomes in patients with hepatopancreatobiliary and colorectal cancer selected for resection.
    Eur J Surg Oncol. 2024;50:108509.
    >> Share

  201. GUO Z, Zhang Z
    Reply to "Harnessing machine learning to predict colorectal cancer metastasis: A promising artificial intelligence frontier".
    Eur J Surg Oncol. 2024 Jun 18:108492. doi: 10.1016/j.ejso.2024.108492.
    >> Share

  202. GAO Z, Qi X, Wang R, Wen Z, et al
    Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108474.
    >> Share

  203. KIM S, Huh JW, Lee WY, Yun SH, et al
    Predicting survival in locally advanced rectal cancer with effective chemoradiotherapy response.
    Eur J Surg Oncol. 2024;50:108361.
    >> Share

  204. MARJASUO ST, Lehtimaki TE, Koskenvuo LE, Lepisto AH, et al
    Impact of mesorectal extranodal tumor deposits in magnetic resonance imaging on outcome of rectal cancer patients.
    Eur J Surg Oncol. 2024;50:108337.
    >> Share

  205. CRIPPA J, Magistro C, Montroni I, Borroni G, et al
    Charting connections: A systematic review of colorectal surgery research networks.
    Eur J Surg Oncol. 2024;50:108322.
    >> Share

  206. ZHOU L, Zhang Z, Wang L
    Treatment of anterior resection syndrome: A systematic review and network meta-analysis.
    Eur J Surg Oncol. 2024;50:108336.
    >> Share

  207. HOOGTEIJLING TJ, Abu Hilal M, Zimmitti G, Aghayan DL, et al
    Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study.
    Eur J Surg Oncol. 2024;50:108309.
    >> Share

  208. PETRELLI F, Arru M, Colombo S, Cavallone M, et al
    BRAF mutations and survival with surgery for colorectal liver metastases: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108306.
    >> Share

  209. DIETZ MV, Hannink G, Said I, van der Zant FA, et al
    Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Eur J Surg Oncol. 2024;50:108294.
    >> Share

  210. KHAN JS, Piozzi GN, Rouanet P, Saklani A, et al
    Robotic beyond total mesorectal excision for locally advanced rectal cancers: Perioperative and oncological outcomes from a multicentre case series.
    Eur J Surg Oncol. 2024;50:108308.
    >> Share

  211. GEFFEN EGMV, Nederend J, Sluckin TC, Hazen SJA, et al
    Prognostic significance of MRI-detected extramural venous invasion according to grade and response to neo-adjuvant treatment in locally advanced rectal cancer A national cohort study after radiologic training and reassessment.
    Eur J Surg Oncol. 2024;50:108307.
    >> Share

  212. VAN HAM NCM, Glazemakers S, van der Ende-van Loon M, Nieuwenhuijzen GAP, et al
    Factors associated with one-year mortality after curative surgery for primary clinical T4 and locally recurrent rectal cancer in elderly patients.
    Eur J Surg Oncol. 2024;50:108259.
    >> Share

  213. DE GRAAFF MR, Klaase JM, Dulk MD, Buis CI, et al
    Outcomes of liver surgery: A decade of mandatory nationwide auditing in the Netherlands.
    Eur J Surg Oncol. 2024;50:108264.
    >> Share

  214. TEN CATE DWG, Molenaar CJL, Garcia RS, Bojesen RD, et al
    Multimodal prehabilitation in elective oncological colorectal surgery enhances postoperative functional recovery: A secondary analysis of the PREHAB randomized clinical trial.
    Eur J Surg Oncol. 2024;50:108270.
    >> Share

    May 2024
  215. AZLAN A, Rafaqat Z, Ahmad A
    Improving machine learning predictions for metastases in colorectal cancer.
    Eur J Surg Oncol. 2024 May 25:108440. doi: 10.1016/j.ejso.2024.108440.
    >> Share

  216. GUO Z, Zhang Z
    Reply to "Improving machine learning predictions for metastases in colorectal cancer".
    Eur J Surg Oncol. 2024 May 24:108441. doi: 10.1016/j.ejso.2024.108441.
    >> Share

  217. CERESOLI M, Pedrazzani C, Pellegrino L, Ficari F, et al
    Early non compliance to enhanced recovery pathway might be an alert for underlying complications following colon surgery.
    Eur J Surg Oncol. 2024;50:106650.
    >> Share

    April 2024
  218. GUO Z, Zhang Z, Liu L, Zhao Y, et al
    Machine learning for predicting liver and/or lung metastasis in colorectal cancer: A retrospective study based on the SEER database.
    Eur J Surg Oncol. 2024;50:108362.
    >> Share

  219. ZHOU X, Lu Y, Wu Y, Yu Y, et al
    Construction and validation of a deep learning prognostic model based on digital pathology images of stage III colorectal cancer.
    Eur J Surg Oncol. 2024;50:108369.
    >> Share

  220. ZHENG Y, Wang J, Sun L
    Reply to: Unveiling controversies: The role of HIPEC in colorectal cancer peritoneal metastasis.
    Eur J Surg Oncol. 2024 Apr 23:108344. doi: 10.1016/j.ejso.2024.108344.
    >> Share

  221. KATAOKA K, Ouchi A, Suwa Y, Hirano H, et al
    Localized colorectal cancer database integrating 4 randomized controlled trials; (JCOG2310A).
    Eur J Surg Oncol. 2024;50:108354.
    >> Share

  222. SAQIB HWU, Abdullah A, Majid A
    "Unveiling controversies: The role of HIPEC in colorectal cancer peritoneal metastasis".
    Eur J Surg Oncol. 2024 Apr 16:108345. doi: 10.1016/j.ejso.2024.108345.
    >> Share

  223. CUIJPERS ACM, Lubbers T, Dronkers JJ, Heldens AFJM, et al
    Development and external validation of preoperative clinical prediction models for postoperative outcomes including preoperative aerobic fitness in patients approaching elective colorectal cancer surgery.
    Eur J Surg Oncol. 2024;50:108338.
    >> Share

  224. QIAN C, Yang W, Li M, Feng Y, et al
    Negative prognostic impact of Co-mutations in TGFbeta and TP53 pathways in surgically resected rectal tumors following neoadjuvant chemoradiotherapy.
    Eur J Surg Oncol. 2024;50:108242.
    >> Share

  225. KNITTER S, Raschzok N, Hillebrandt KH, Benzing C, et al
    Short-term postoperative outcomes of lymphadenectomy for cholangiocarcinoma, hepatocellular carcinoma and colorectal liver metastases in the modern era of liver surgery: Insights from the StuDoQ|Liver registry.
    Eur J Surg Oncol. 2024;50:108010.
    >> Share

  226. CAI Y, Chen M, Ye F, Liu Z, et al
    The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage.
    Eur J Surg Oncol. 2024;50:108001.
    >> Share

    March 2024
  227. MALIK HZ, Siriwardena AK
    Towards standardized terminology for patients with synchronous colorectal cancer and liver metastases.
    Eur J Surg Oncol. 2024;50:108315.
    >> Share

  228. NUIJENS BW, Lindeboom R, van den Broek JJ, Geenen RWF, et al
    A prediction model for lung metastases in patients with indeterminate pulmonary nodules in newly diagnosed colorectal cancer.
    Eur J Surg Oncol. 2024;50:108305.
    >> Share

  229. LENNON D, Ryan OK, Ryan EJ, Martin ST, et al
    "Reply to: An insight into the distribution patterns of metastatic lymph nodes in non-metastatic splenic flexure colon cancer: Rationale for surgical management strategies".
    Eur J Surg Oncol. 2024 Mar 11:108256. doi: 10.1016/j.ejso.2024.108256.
    >> Share

  230. WANG X
    An insight into the distribution patterns of metastatic lymph nodes in non-metastatic splenic flexure colon cancer: Rationale for surgical management strategies.
    Eur J Surg Oncol. 2024 Mar 7:108255. doi: 10.1016/j.ejso.2024.108255.
    >> Share

  231. VAN DER HULST HC, van der Bol JM, Bastiaannet E, Portielje JEA, et al
    The effect of prehabilitation on long-term survival and hospital admissions in older patients undergoing elective colorectal cancer surgery.
    Eur J Surg Oncol. 2024;50:108244.
    >> Share

  232. VOIGT KR, de Graaff MR, Verhoef C, Kazemier G, et al
    Association of modified textbook outcome and overall survival after surgery for colorectal liver metastases: A nationwide analysis.
    Eur J Surg Oncol. 2024;50:107972.
    >> Share

    February 2024
  233. THOMASSEN BJM, Kimman ML, Somers AMJ, Ponds RWHM, et al
    The Assessment of Burden of ColoRectal Cancer (ABCRC)-tool; a validity and reliability study.
    Eur J Surg Oncol. 2024;50:108032.
    >> Share

  234. MAKI H, Haddad A, Lendoire M, Newhook TE, et al
    Evolving survival gains in patients with young-onset colorectal cancer and synchronous resectable liver metastases.
    Eur J Surg Oncol. 2024;50:108057.
    >> Share

  235. BOLDRIN V, Khaled C, El Asmar A, Kamden L, et al
    Predictive factors of non-completion of cytoreductive surgery in colorectal peritoneal metastasis.
    Eur J Surg Oncol. 2024;50:107251.
    >> Share

    October 2023
  236. BORG J, Garm Spindler KL, Havelund BM, Sorensen MM, et al
    Risk factors and outcome following salvage surgery for squamous cell carcinoma of the anus.
    Eur J Surg Oncol. 2023;49:107050.
    >> Share

  237. ARJONA-SANCHEZ A, Aziz O, Passot G, Salti G, et al
    Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry.
    Eur J Surg Oncol. 2023;49:107001.
    >> Share

  238. CERDAN-SANTACRUZ C, Cano-Valderrama O, Santos Rancano R, Teres LB, et al
    "Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study".
    Eur J Surg Oncol. 2023;49:106962.
    >> Share

    March 2023
  239. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
    External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Eur J Surg Oncol. 2023;49:604-610.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016